Literature DB >> 9889216

Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA.

D D Panteleeff1, G John, R Nduati, D Mbori-Ngacha, B Richardson, J Kreiss, J Overbaugh.   

Abstract

PCR is a highly sensitive method for the detection of human immunodeficiency virus type 1 (HIV-1) nucleic acids in blood mononuclear cells and plasma. However, blood separation techniques require extensive laboratory support systems and are difficult when a limited volume of blood is available, which is often the case for infants. The use of blood samples stored on filter paper has many advantages for the detection of perinatal HIV-1 infection, but current methods require extraction and purification of target DNA prior to PCR amplification. We report a highly sensitive and rapid method for the extraction and detection of HIV-1 DNA in infant blood samples stored on filter papers. Because this rapid protocol does not involve steps for the removal of potential inhibitors of the PCR, the highest sensitivity is achieved by testing the filter paper lysate in quadruplicate. Assays for HIV-1 DNA were done by using nested PCR techniques that amplify HIV-1 gag DNA from blood spot samples on filter paper and from corresponding viably frozen mononuclear cells separated from venous blood samples obtained from 111 infants born to HIV-1-seropositive mothers. PCR results with blood from filter papers showed 100% specificity (95% confidence internal [CI] 93.1 to 100%) and 96% (95% CI, 88.65 to 98.9%) and 88% (95% CI, 79.2 to 94.5%) sensitivity (for quadruplicate and duplicate tests, respectively) compared to PCR results with blood mononuclear cells. Moreover, this method could detect HIV-1 sequences of multiple subtypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889216      PMCID: PMC84304     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Detection of incident HIV infection by PCR compared to serology.

Authors:  S Read; S Cassol; R Coates; C Major; B McLaughlin; T Salas; A Francis; M Fanning; D MacFadden; F Shepherd
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

2.  A novel polymerase chain reaction method for detection of human immunodeficiency virus in dried blood spots on filter paper.

Authors:  J Yourno; J Conroy
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

3.  DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening.

Authors:  E R McCabe; S Z Huang; W K Seltzer; M L Law
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

4.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.

Authors:  K A Clouse; D Powell; I Washington; G Poli; K Strebel; W Farrar; P Barstad; J Kovacs; A S Fauci; T M Folks
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

6.  Sickle-cell anemia and other hemoglobinopathies. Procedures and strategy for screening employing spots of blood on filter paper as specimens.

Authors:  M D Garrick; P Dembure; R Guthrie
Journal:  N Engl J Med       Date:  1973-06-14       Impact factor: 91.245

7.  Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.

Authors:  M Poss; H L Martin; J K Kreiss; L Granville; B Chohan; P Nyange; K Mandaliya; J Overbaugh
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns.

Authors:  R Hoff; V P Berardi; B J Weiblen; L Mahoney-Trout; M L Mitchell; G F Grady
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

9.  Limitations in the laboratory diagnosis of vertically acquired HIV infection.

Authors:  T A Rakusan; R H Parrott; J L Sever
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

10.  Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction.

Authors:  S Cassol; T Salas; M Arella; P Neumann; M T Schechter; M O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

View more
  81 in total

Review 1.  The use of the dried blood spot sample in epidemiological studies.

Authors:  S P Parker; W D Cubitt
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

Authors:  Alison L Drake; Alison C Roxby; Francisca Ongecha-Owuor; James Kiarie; Grace John-Stewart; Anna Wald; Barbra A Richardson; Jane Hitti; Julie Overbaugh; Sandra Emery; Carey Farquhar
Journal:  J Infect Dis       Date:  2011-12-06       Impact factor: 5.226

3.  Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival.

Authors:  Adam Aluisio; Barbra A Richardson; Rose Bosire; Grace John-Stewart; Dorothy Mbori-Ngacha; Carey Farquhar
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

4.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

5.  Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.

Authors:  Kim Steegen; Stanley Luchters; Els Demecheleer; Kenny Dauwe; Kishor Mandaliya; Walter Jaoko; Jean Plum; Marleen Temmerman; Chris Verhofstede
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

6.  Birth size and early pneumonia predict linear growth among HIV-exposed uninfected infants.

Authors:  Emily L Deichsel; Patricia B Pavlinac; Barbra A Richardson; Dorothy Mbori-Ngacha; Judd L Walson; Christine J McGrath; Carey Farquhar; Rose Bosire; Elizabeth Maleche-Obimbo; Grace C John-Stewart
Journal:  Matern Child Nutr       Date:  2019-08-06       Impact factor: 3.092

7.  Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission.

Authors:  Carey Farquhar; James N Kiarie; Barbra A Richardson; Marjory N Kabura; Francis N John; Ruth W Nduati; Dorothy A Mbori-Ngacha; Grace C John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

8.  Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.

Authors:  Michael H Chung; James N Kiarie; Barbra A Richardson; Dara A Lehman; Julie Overbaugh; Grace C John-Stewart
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

9.  Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability.

Authors:  Don Brambilla; Cheryl Jennings; Grace Aldrovandi; James Bremer; Anne Marie Comeau; Sharon A Cassol; Ruth Dickover; J Brooks Jackson; Jane Pitt; John L Sullivan; Ann Butcher; Lynell Grosso; Patricia Reichelderfer; Susan A Fiscus
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.

Authors:  Jennifer A Slyker; Corey Casper; Kenneth Tapia; Barbra Richardson; Lisa Bunts; Meei-Li Huang; Elizabeth Maleche-Obimbo; Ruth Nduati; Grace John-Stewart
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.